悦耳代真
Lv12
14 积分
2024-09-06 加入
-
CREB: A Promising Therapeutic Target for Treating Psychiatric Disorders
6小时前
已完结
-
Effects of Xanomeline, a Selective Muscarinic Receptor Agonist, on Cognitive Function and Behavioral Symptoms in Alzheimer Disease
1天前
已完结
-
Emraclidine, a novel positive allosteric modulator of cholinergic M4 receptors, for the treatment of schizophrenia: a two-part, randomised, double-blind, placebo-controlled, phase 1b trial
3天前
已完结
-
Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study 2016
5天前
已完结
-
Transaminases Provide Key Chiral Building Blocks for the Synthesis of Selective M1/M4 Agonists
7天前
已完结
-
Schizophrenia—An Overview
13天前
已完结
-
Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019
14天前
已完结
-
Discovery of Selective M4 Muscarinic Acetylcholine Receptor Agonists with Novel Carbamate Isosteres
24天前
已完结
-
Transaminases Provide Key Chiral Building Blocks for the Synthesis of Selective M1/M4 Agonists
24天前
已完结
-
cAMP detection methods in HTS: selecting the best from the rest
24天前
已完结